Evaluation of all Types of Metabolic Bariatric Surgery and its Consequences: a Systematic Review and Meta-Analysis
Considering conflicting results on the consequences of all types of obesity surgery, we were to summarize them via a systematic review.
Electronic literature search was done via scientific search engines. After the removal of duplicates and selection of articles of interest, 771 studies were included.
Insulin resistance indicators were significantly improved after bariatric surgery. Leptin was also significantly decreased while adiponectin was significantly increased. Although the level of metabolic hormones changed after bariatric surgery, they were not statistically significant. Inflammation indicators were significantly decreased. Significant reduction was also detected in PAI-1 and sICAM-1.
Bariatric surgery is beneficial in morbidly obese patients. Although treating obesity in a surgical way may cause some complications, the weight loss is generally safe and effective.
KeywordsObesity Bariatric surgery Metabolic Weight Insulin resistance
Research reported in this publication was supported by the Elite Researcher Grant Committee under award number 958714 from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran.
Compliance with Ethical Standards
Conflict of Interest
Author 2 reports grants from National Institutes for Medical Research Development (NIMAD), during the conduct of the study. All of the other authors report no conflict of interest.
Informed Consent Statement
Informed consent does not apply.
Ethical Approval Statement
This article does not contain any studies with human participants or animals performed by any of the authors.
- 4.Ross R. Atherosclerosis-an inflammatory diseaseN Engl J Med 1999; 340: 2115-26. CrossRef Google Scholar 1999.Google Scholar
- 30.Heptulla R, Smitten A, Teague B, et al. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. The Journal of Clinical Endocrinology & Metabolism. 2001;86(1):90–6.Google Scholar
- 33.Siejka A, Jankiewicz-Wika J, Kołomecki K, et al. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. Cytokine. 2013;64(2):490–3.CrossRefGoogle Scholar
- 49.Zhou D, Jiang X, Ding W, et al. Impact of bariatric surgery on ghrelin and obestatin levels in obesity or type 2 diabetes mellitus rat model. Journal of diabetes research. 2014;2014Google Scholar
- 52.Chronaiou A, Tsoli M, Kehagias I, et al. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obes Surg. 2012;22(11):1761–70.CrossRefGoogle Scholar
- 62.Dandona P, Weinstock R, Thusu K, et al. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. The Journal of Clinical Endocrinology & Metabolism. 1998;83(8):2907–10.Google Scholar
- 65.Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? The Journal of Clinical Endocrinology & Metabolism. 2001;86(7):3257–65.Google Scholar
- 72.Flevaris P, Vaughan D, editors. The role of plasminogen activator inhibitor type-1 in fibrosis. Seminars in thrombosis and hemostasis; 2017: Thieme Medical Publishers.Google Scholar
- 73.Khan SS, Lloyd-Jones DM, Chan C, Liu K, Cushman M, Kestenbaum B, et al. Association of plasminogen activator inhibitor-1 with prevalent and incident obesity is independent of inflammatory markers: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart Assoc; 2015.Google Scholar
- 76.Morel O, Luca F, Grunebaum L, Jesel L, Meyer N, Desprez D, et al. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. International journal of obesity (2005). 2011 Dec;35(12):1479–86.CrossRefGoogle Scholar